Rosenberg, S A <br/><br/>
Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma.  [electronic resource] 

 -  Nature medicine  Mar 1998 
 - 321-7 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>1078-8956 
<br/><br/><label>Standard No.: </label>10.1038/nm0398-321  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Cancer Vaccines--therapeutic use<br/>Drug Therapy, Combination<br/>Evaluation Studies as Topic<br/>Female<br/>HLA-A2 Antigen--immunology<br/>Humans<br/>Immunization<br/>Interleukin-2--therapeutic use<br/>Lung Neoplasms--secondary<br/>Melanoma--therapy<br/>Membrane Glycoproteins--therapeutic use<br/>Middle Aged<br/>Neoplasm Metastasis<br/>Oligopeptides--therapeutic use<br/>Peptide Fragments--therapeutic use<br/>gp100 Melanoma Antigen